EUVIMEDEUVIMED entdecken
Open Access

A stapled chromogranin A-derived peptide homes in on tumors that express αvβ6 or αvβ8 integrins

Matteo Monieri, Paolo Rainone, Angelina Sacchi, Alessandro Gori, Anna Maria Gasparri, Angela Coliva, Antonio Citro, Benedetta Ferrara, Martina Policardi, Silvia Valtorta, Arianna Pocaterra, Massimo Alfano und 5 weitere

International Journal of Biological Sciences · 2023

DOI: 10.7150/ijbs.76148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2023. Verfasst von Matteo Monieri und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Prostatic Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rationale

The αvβ6- and αvβ8-integrins, two cell-adhesion receptors upregulated in many tumors and involved in the activation of the latency associated peptide (LAP)/TGFβ complex, represent potential targets for tumor imaging and therapy. We investigated the tumor-homing properties of a chromogranin A-derived peptide containing an RGDL motif followed by a chemically stapled alpha-helix (called "5a"), which selectively recognizes the LAP/TGFβ complex-binding site of αvβ6 and αvβ8.

Methods

Peptide 5a was labeled with IRDye 800CW (a near-infrared fluorescent dye) or with 18F-NOTA (a label for positron emission tomography (PET)); the integrin-binding properties of free peptide and conjugates were then investigated using purified αvβ6/αvβ8 integrins and various αvβ6/αvβ8 single - or double-positive cancer cells; tumor-homing, biodistribution and imaging properties of the conjugates were investigated in subcutaneous and orthotopic αvβ6-positive carcinomas of the pancreas, and in mice bearing subcutaneous αvβ8-positive prostate tumors.

Results

In vitro studies showed that 5a can bind both integrins with high affinity and inhibits cell-mediated TGFβ activation. The 5a-IRDye and 5a-NOTA conjugates could bind purified αvβ6/αvβ8 integrins with no loss of affinity compared to free peptide, and selectively recognized various αvβ6/αvβ8 single- or double-positive cancer cells, including cells from pancreatic carcinoma, melanoma, oral mucosa, bladder and prostate cancer. In vivo static and dynamic optical near-infrared and PET/CT imaging and biodistribution studies, performed in mice with subcutaneous and orthotopic αvβ6-positive carcinomas of the pancreas, showed high target-specific uptake of fluorescence- and radio-labeled peptide by tumors and low non-specific uptake in other organs and tissues, except for excretory organs. Significant target-specific uptake of fluorescence-labeled peptide was also observed in mice bearing αvβ8-positive prostate tumors.

Conclusions

The results indicate that 5a can home to αvβ6- and/or αvβ8-positive tumors, suggesting that this peptide can be exploited as a ligand for delivering imaging or anticancer agents to αvβ6/αvβ8 single- or double-positive tumors, or as a tumor-homing inhibitor of these TGFβ activators.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsCarcinomaProstatic NeoplasmsMaleAnimalsMiceHumansChromogranin APositron Emission Tomography Computed TomographyTissue DistributionPeptidesIntegrinsTransforming Growth Factor beta

Stichwörter der Autor:innen

RGD motifTGFβcancer.chromogranin Aαvβ6 and αvβ8 integrins

Substanzen

Chromogranin APeptidesIntegrinsTransforming Growth Factor beta

Autor:innen und Institutionen

  • Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
  • Experimental Imaging Center, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Istituto di Scienze e Tecnologie Chimiche, C.N.R., Milan, Italy.
  • Diabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Institute of Molecular Bioimaging and Physiology of C.N.R., Segrate, Italy.

Zitieren

APA

Monieri, M., Rainone, P., Sacchi, A., Gori, A., Gasparri, A. M., Coliva, A., Citro, A., Ferrara, B., Policardi, M., Valtorta, S., Pocaterra, A., Alfano, M., Sheppard, D., Piemonti, L., Moresco, R. M., Corti, A., & Curnis, F. (2023). A stapled chromogranin A-derived peptide homes in on tumors that express αvβ6 or αvβ8 integrins. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.76148

Vancouver

Monieri M, Rainone P, Sacchi A, Gori A, Gasparri AM, Coliva A, et al. A stapled chromogranin A-derived peptide homes in on tumors that express αvβ6 or αvβ8 integrins. International Journal of Biological Sciences. 2023. doi:10.7150/ijbs.76148

BibTeX
@article{Monieri2023,
  author = {Monieri, Matteo and Rainone, Paolo and Sacchi, Angelina and Gori, Alessandro and Gasparri, Anna Maria and Coliva, Angela and Citro, Antonio and Ferrara, Benedetta and Policardi, Martina and Valtorta, Silvia and Pocaterra, Arianna and Alfano, Massimo and Sheppard, Dean and Piemonti, Lorenzo and Moresco, Rosa Maria and Corti, Angelo and Curnis, Flavio},
  title = {A stapled chromogranin A-derived peptide homes in on tumors that express αvβ6 or αvβ8 integrins},
  journal = {International Journal of Biological Sciences},
  year = {2023},
  doi = {10.7150/ijbs.76148}
}
Kostenlos starten →